Half-year report · HY
3583.TEDINET S100WZXL
Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥6.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥352m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥489m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥351m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥814m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥454m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥353m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥452m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥355m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥580m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥302m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥355m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥302m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥10.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥9.8bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥9.6bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.0bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥3.1bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.0bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.5bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.7bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.7bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.5bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥277m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥637m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥313m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥47m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥160m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥202m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥248m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥562m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥391m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥129.18 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥209.05 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥108.1 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 69.8% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.6% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Medical Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥829m |
| Medical Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥827m |
| Medical Productsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1m |
| Medical Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥58m |
| Technological Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Technological Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Technological Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥448m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥507m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥507m |
| Medical Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥817m |
| Medical Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥817m |
| Medical Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥513,000 |
| Medical Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥65m |
| Technological Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.2bn |
| Technological Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.2bn |
| Technological Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥598m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥513,000 |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥663m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥513,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥663m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 531
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E00584-000TechnologicalProductsReportableSegmentsMember | 598077000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E00584-000MedicalProductsReportableSegmentsMember | 65337000 | JPY |
| Operating income | Prior1InterimDuration_ReportableSegmentsMember | 663415000 | JPY |
| Operating income | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 663415000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E00584-000TechnologicalProductsReportableSegmentsMember | 2229054000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E00584-000MedicalProductsReportableSegmentsMember | 827459000 | JPY |
| Revenues from external customers | InterimDuration_ReportableSegmentsMember | 3056514000 | JPY |
| Revenues from external customers | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 3056514000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E00584-000TechnologicalProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E00584-000MedicalProductsReportableSegmentsMember | 1212000 | JPY |
| Transactions with other segments | InterimDuration_ReportableSegmentsMember | 1212000 | JPY |
| Transactions with other segments | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 1212000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E00584-000TechnologicalProductsReportableSegmentsMember | 2229054000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E00584-000MedicalProductsReportableSegmentsMember | 828671000 | JPY |
| Net sales | InterimDuration_ReportableSegmentsMember | 3057726000 | JPY |
| Net sales | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 3057726000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E00584-000TechnologicalProductsReportableSegmentsMember | 448182000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E00584-000MedicalProductsReportableSegmentsMember | 58402000 | JPY |
| Operating income | InterimDuration_ReportableSegmentsMember | 506584000 | JPY |
| Operating income | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 506584000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-11-10 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第141期中(自 2025年４月１日 至 2025年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)オーベクス株式会社 | |
| Company name in english cover page | FilingDateInstant | AuBEX CORPORATION | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 栗 原 則 義 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都墨田区両国四丁目31番11号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03(6701)3200(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役管理部長 塚 越 孝 弘 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都墨田区両国四丁目31番11号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03(6701)3200(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役管理部長 塚 越 孝 弘 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00584 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 35830 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)オーベクス株式会社 | |
| Filer name in english | FilingDateInstant | AuBEX CORPORATION | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2025-04-01 | |
| Current period end date | FilingDateInstant | 2025-09-30 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |